Cumberland Pharmaceuticals (CPIX) Receivables - Net (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) posted Receivables - Net of $14.3 million for Q1 2026, down 15.83% sequentially from $16.9 million in Q4 2025, and up 35.98% YoY from $10.5 million in Q1 2025.
Cumberland Pharmaceuticals (CPIX) Receivables - Net (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has reported Receivables - Net for 17 years, with the latest figure at $14.3 million in Q1 2026.
- Quarterly Receivables - Net rose 35.98% year-over-year to $14.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.3 million (up 35.98% YoY) and the FY2025 annual result came in at $16.9 million, up 44.81% from the prior year.
- Receivables - Net declined to $14.3 million in Q1 2026 per CPIX's latest filing, from $16.9 million in the prior quarter.
- Over five years, Receivables - Net peaked at $16.9 million in Q4 2025 and troughed at $9.8 million in Q4 2023.
- A 5-year average of $12.5 million and a median of $12.2 million in 2023 frame the typical range for Receivables - Net.
- The sharpest annual moves came in 2022 and 2024: Receivables - Net jumped 91.41% in 2022, then declined 26.72% in 2024.
- Over 5 years, Receivables - Net stood at $13.2 million in 2022, then fell by 25.87% to $9.8 million in 2023, then rose by 19.91% to $11.7 million in 2024, then surged by 44.81% to $16.9 million in 2025, then retreated by 15.83% to $14.3 million in 2026.
- According to Business Quant data, Receivables - Net over the past three periods registered $14.3 million, $16.9 million, and $10.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Cumberland Pharmaceuticals | 114.68 Mn | 110.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.42 Mn |
| Jun 30, 2026 | 13.42 Mn |
| Mar 31, 2026 | 14.26 Mn |
| Mar 31, 2026 | 14.26 Mn |
| Dec 31, 2025 | 16.94 Mn |
| Dec 31, 2025 | 16.94 Mn |
| Sep 30, 2025 | 10.43 Mn |
| Sep 30, 2025 | 10.43 Mn |
| Jun 30, 2025 | 10.32 Mn |
| Jun 30, 2025 | 10.32 Mn |
| Mar 31, 2025 | 10.49 Mn |
| Mar 31, 2025 | 10.49 Mn |
| Dec 31, 2024 | 11.70 Mn |
| Dec 31, 2024 | 11.70 Mn |
| Sep 30, 2024 | 11.31 Mn |
| Sep 30, 2024 | 11.31 Mn |
| Jun 30, 2024 | 11.62 Mn |
| Jun 30, 2024 | 11.62 Mn |
| Mar 31, 2024 | 10.65 Mn |
| Mar 31, 2024 | 10.65 Mn |